Skip to main content
. 2016 Oct;359(1):91–101. doi: 10.1124/jpet.116.234096

Fig. 6.

Fig. 6.

Activation of the PXR attenuates intestinal permeability induced by TLR4 activation in WT mice (A), but not Pxr−/− mice (B). Male WT and Pxr−/− mice were pretreated with the rodent-specific PXR agonist PCN (25 mg/kg, i.p.), then administered the selective TLR4 agonist KDO2 (200 μg per mouse). After 24 hours, intestinal permeability was assessed by FITC-dextran flux assay. *P < 0.05 compared with control and PCN-treated mice; #P < 0.05 compared with KDO2 group (n = 5–6 per group).